PharmaCyte Biotech Announces Appointment of International Diabetes Expert to Scientific Advisory Board
November 19, 2015 10:40 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Nov. 19, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Appoints International Diabetes Expert to Its Scientific Advisory Board
November 19, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Nov. 19, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Obtains Orphan Drug Designation in Europe for Its Pancreatic Cancer Treatment
November 17, 2015 09:21 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Nov. 17, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Scientific Advisory Board Member Named Clinical Director of Prestigious Boston Cancer Center
November 10, 2015 10:17 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Nov. 10, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Hosts 2nd Annual Meeting of International Diabetes Consortium Developing Novel Treatment for Diabetes
October 29, 2015 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Oct. 29, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Management Interviewed to Discuss Key Aspects of New Pancreatic Cancer Clinical Trial Design
October 23, 2015 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Oct. 23, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Clinical Trial Designed to Expand Standard of Care Therapy for Pancreatic Cancer
October 21, 2015 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Oct. 21, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech to Conduct Pancreatic Cancer Clinical Trial in United States
October 19, 2015 09:48 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Oct. 19, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Designs Clinical Trial to Meet Critical Unmet Medical Need
October 14, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Oct. 14, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech CEO in Europe to Secure Orphan Designation With the EMA
October 07, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Oct. 07, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...